Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 9.4.2024Bausch Health Ireland Limited (BAU-1)40325Carbo medicinalis (tbl 20(2x10)x300 mg (blis.Al/PVC/PVDC))12.4.2024O
 9.4.2024PRO.MED.CS Praha a.s. (PMP-1)8562DURSOSAN 400 mg filmom obalené tablety (tbl flm 100x400mg (blis.PVC/PVDC/Al))9.4.2024U
 8.4.2024Viatris Healthcare Limited (VIM-1)26529Kreon 25 000 (cps end 50x300 mg (fľ.HDPE))9.4.2024O
 8.4.2024Novartis Slovakia s.r.o. (NVL-2)14922Trileptal 300 mg (tbl flm 50x300 mg (blis.PVC/PE/PVDC/Al))8.4.2024R
 8.4.2024MEDOCHEMIE Ltd. (MOE)0324DSOFENTIL 5 mikrogramov/ml injekčný/infúzny roztok (sol ijf 5x10 ml (amp.skl.))1.4.2024O
 8.4.2024MEDOCHEMIE Ltd. (MOE)6341ASULCEF 2 g (plo ijf 10x2 g (liek.inj.skl.))1.4.2024R
 8.4.2024MEDOCHEMIE Ltd. (MOE)33522MEDOCLAV 625 mg (tbl flm 21x625 mg (blis.Al/PVC))1.4.2024O
 8.4.2024MEDOCHEMIE Ltd. (MOE)9446BZEPILEN 1 g (plo ijf 50x1 g (liek.inj.skl.))1.4.2024R
 8.4.2024MEDOCHEMIE Ltd. (MOE)0907CSiranalen 150 mg tvrdé kapsuly (cps dur 84x150 mg (blis.PVC/PVDC/Al))1.4.2024R
 8.4.2024MEDOCHEMIE Ltd. (MOE)8859AMEDOSPIR 25 mg (tbl 100x25 mg (blis.PVC/Al))1.4.2024R
 8.4.2024MEDOCHEMIE Ltd. (MOE)39164MEDOCLAV 1 g (tbl flm 14x1 g (blis.Al/PVC))1.4.2024R
 8.4.2024MEDOCHEMIE Ltd. (MOE)67541ALMIRAL 50 mg (tbl ent 20x50 mg (blis.PVC/Al))1.4.2024R
 8.4.2024MEDOCHEMIE Ltd. (MOE)37109ARKETIS 30 mg (tbl 30x30 mg (blis.PVC/Al))1.4.2024O
 8.4.2024MEDOCHEMIE Ltd. (MOE)59188BETAC (tbl flm 30x20 mg (blister PVC/Al))1.4.2024R
 8.4.2024AS KALCEKS (AKA-1)4574DNorepinephrine Kalceks 1 mg/ml koncentrát na infúzny roztok (con inf 10x1 ml (amp.skl.))10.4.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To